Bio-Techne (TECH) Current Deferred Tax Assets (2010 - 2015)
Bio-Techne (TECH) recorded quarterly Current Deferred Tax Assets of $11.5 million in Q4 2015, down 30.96% quarter-over-quarter from $16.7 million in Q3 2015, and down 12.05% on a YoY basis from $13.1 million in Q4 2014.
Bio-Techne (TECH) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Bio-Techne's Current Deferred Tax Assets history runs 5 years deep, the most recent figure standing at $11.5 million for Q4 2015.
- In Q4 2015, Current Deferred Tax Assets fell 12.05% year-over-year to $11.5 million; the TTM figure through Dec 2015 stood at $11.5 million (down 12.05% YoY), while the FY2015 annual figure was $11.5 million, up 19.62% from the prior year.
- Current Deferred Tax Assets was $11.5 million for Q4 2015 at Bio-Techne, down from $16.7 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $19.1 million in Q3 2014 to a low of $5.8 million in Q2 2011.
- Historically, Current Deferred Tax Assets has averaged $11.2 million across 4 years, with a median of $11.2 million in 2011.
- The sharpest annual moves came in 2011 and 2014: Current Deferred Tax Assets sank 56.67% in 2011, then surged 100.99% in 2014.
- A 4-year view of Current Deferred Tax Assets shows it stood at $12.9 million in 2011, then dropped by 23.55% to $9.9 million in 2013, then surged by 32.52% to $13.1 million in 2014, then fell by 12.05% to $11.5 million in 2015.
- The last three Current Deferred Tax Assets figures came in at $11.5 million (Q4 2015), $16.7 million (Q3 2015), and $11.5 million (Q2 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 11.51 Mn |
| Dec 31, 2015 | 11.51 Mn |
| Sep 30, 2015 | 16.68 Mn |
| Sep 30, 2015 | 16.68 Mn |
| Jun 30, 2015 | 11.51 Mn |
| Jun 30, 2015 | 11.51 Mn |
| Mar 31, 2015 | 11.73 Mn |
| Mar 31, 2015 | 11.73 Mn |
| Dec 31, 2014 | 13.09 Mn |
| Dec 31, 2014 | 13.09 Mn |
| Sep 30, 2014 | 19.15 Mn |
| Sep 30, 2014 | 19.15 Mn |
| Jun 30, 2014 | 9.62 Mn |
| Jun 30, 2014 | 9.62 Mn |
| Mar 31, 2014 | 8.51 Mn |
| Mar 31, 2014 | 8.51 Mn |
| Dec 31, 2013 | 9.88 Mn |
| Dec 31, 2013 | 9.88 Mn |
| Sep 30, 2013 | 9.53 Mn |
| Sep 30, 2013 | 9.53 Mn |